New clinical trial : personalized medicine in diabetes using a nanotechnology platform


Rambam Health Care Campus in Israel will launch in collaboration with Technion/Israel Institute of Technology a phase I clinical trial about “personalized medicine in diabetes using a nanotechnology platform”, registered in the Clinicaltrials.gov database under reference NCT01268813. In this trial, breath samples will be collected in inert respiratory bag from diabetic and healthy volunteers, and analyzed using a chamber containing nano-chemical sensors. These samples together with blood samples will additionally be characterized using Gas Chromatography-Mass Spectroscopy (GC-MS). The study is not yet open for participant recruitment.

Advertisements

New phase I clinical trial : antibacterial properties of silicon incorporated with quaternary ammonium polyethylenimine nanoparticles


The Hadassah Medical Organization plan to start in January 2010 a phase I clinical trial entitled “Antibacterial properties of silicon incorporated with quaternary ammonium polyethylenimine nanoparticles” now registered in the Clinicaltrials.gov database under reference NCT01007240. According to this page, “the aim of this study is to evaluate the antibacterial activity of crosslinked quaternary ammonium polyethylenimine (PEI) nanoparticles incorporated at 1-2% w/w in a commercial soft liner material when compared to the commercial soft liner material“.

Nanotechnology.org.il


Nanotechnology.org.il is an information website providing both world news and Israel news in the field of nanotech. It is a media partner of NanoIsrael 2009 (see this post).

NanoIsrael 2009


The NanoIsrael 2009 international nanotechnology conference will take place in Jerusalem (Israël) on March 30th and 31st, 2009. An interactive session planner with the detailed program is available here.